Does incidental prostate cancer after holmium laser enucleation of the prostate cause serious clinical problems?: Retrospective study
Open Access
- 31 October 2025
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (44) , e45529
Abstract
We aimed to investigate the predictive factors, oncologic course and functional outcomes of incidental prostate adenocarcinoma (iPCa) after holmium laser enucleation of the prostate (HoLEP). This study included 577 patients who had undergone HoLEP. Patients with a preoperative diagnosis of prostate cancer or suspected prostate cancer were excluded from the study. Patients were divided into group-1 (iPCa) and group-2 benign prostatic hyperplasia (BPH). Oncological and functional outcomes and complications at 1, 6, and 12 months were compared between the groups. To evaluate the association between clinical and demographic variables, a multivariable-adjusted logistic regression analysis was performed. In total 577 patients were included. iPCa was detected in 2.77% (16/577) of the patients who underwent HoLEP. Prostate specific antigen density had a sensitivity of 50% and specificity of 80.30% (cut-off > 0.07) for predicting iPCa (odds ratio: 0.264; 95% confidence interval: 0.099–0.430; P = .024). In the oncological follow-up of the iPCa and BPH groups, there was no statistically significant difference in prostate specific antigen level at 36 month ( P = .874). Only 1 patient was found to have Gleasen grade (3 + 4) (clinically significant) prostate cancer, since there was no progression in prostate specific antigen follow-up, no additional treatment was performed. The functional results in both the groups were similar at 36 month ( P < .05). Urethral stricture and urinary retention rates were higher in the iPCa group (4/16, 25%). The incidence of urinary infections was higher in the BPH group (1.06%; 6/561). At 36 months, and all patients were continent. The incidence of iPCa detected after HoLEP was low, and most cases were clinically insignificant.Keywords
This publication has 17 references indexed in Scilit:
- Incidental prostate cancer after holmium laser enucleation of the prostate—A narrative reviewAndrologia, 2021
- Management of prostate cancer after holmium laser enucleation of the prostateUrologic Oncology: Seminars and Original Investigations, 2021
- Efficacy, safety, and perioperative outcomes of holmium laser enucleation of the prostate—a comparison of patients with lower urinary tract symptoms and urinary retentionLasers in Medical Science, 2020
- The diagnostic value of prostate cancer between holmium laser enucleation of the prostate and transurethral resection of the prostate for benign prostatic hyperplasia: A retrospective comparative studyInternational Journal of Surgery, 2020
- Incidental Prostate Cancer Diagnosis During Holmium Laser Enucleation: Assessment of Predictors, Survival, and Disease ProgressionUrology, 2015
- Prevalence of incidental prostate cancer: A systematic review of autopsy studiesInternational Journal of Cancer, 2015
- Prevalence of Lower Urinary Tract Symptoms and Effect on Quality of Life in a Racially and Ethnically Diverse Random SampleArchives of internal medicine (1960), 2006
- The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence SocietyNeurourology and Urodynamics, 2002
- 5-YEAR OUTCOME OF SURGICAL RESECTION AND WATCHFUL WAITING FOR MEN WITH MODERATELY SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA: A DEPARTMENT OF VETERANS AFFAIRS COOPERATIVE STUDYJournal of Urology, 1998
- A Comparison of Transurethral Surgery with Watchful Waiting for Moderate Symptoms of Benign Prostatic HyperplasiaNew England Journal of Medicine, 1995